Prostatic Neoplasms: all 6,484 studies
Page 54 of 65. Open to participants first (1,415), then studies with results posted, then the rest; newest registration first within each.
- Dose Escalation Study With Cabazitaxel in Combination With Daily Prednisolone in Patients With Hormone Refractory Prostate CancerCompletedNCT01324583Phase 1
- BIBW 2992 (Afatinib) for the Treatment of Patients With HER2-positive, Hormone-refractory Prostate CancerTerminatedNCT01320280Phase 2
- Glivec in Prostate Cancer Patients With Rising PSA Following Radical ProstectomyCompletedNCT01316458Phase 2
- 3D Recording of a Trans-rectal Prostate BiopsyStatus unknownNCT01314456Not applicable
- Efficacy and Safety Study of TOOKAD® Soluble for Localised Prostate Cancer Compared to Active Surveillance.CompletedNCT01310894Phase 3
- Cancer Localization in the Prostate With F-18 Fluorocholine Positron Emission TomographyCompletedNCT01310192Phase 1
- PET Imaging Characteristics of C11-Acetate in Patients With Recurrent Prostate CarcinomaCompletedNCT01304485Phase 2
- Anti-OX40, Cyclophosphamide (CTX) and Radiation in Patients With Progressive Metastatic Prostate CancerCompletedNCT01303705Phase 1
- Comparison of Bone Mineral Loss in Prostate Cancer Patients Who is Receiving GnRH Agonist and -Plus Anti-androgen AgentCompletedNCT01303692
- Feasibility Study on a Nordic Lifestyle Intervention Trial Among Men With Prostate CancerCompletedNCT01300104Not applicable
- Tesetaxel in Chemotherapy-naive Patients With Progressive, Castration-resistant Prostate CancerStatus unknownNCT01296243Phase 2
- Sentinel Lymph Node Detection in Prostate Surgery by LaparoscopyCompletedNCT01296217Not applicable
- Ferumoxytol Enhanced MRI for the Detection of Lymph Node Involvement in Prostate CancerCompletedNCT01296139Phase 1
- MRI in Diagnosing Prostate CancerStatus unknownNCT01292291Not applicable
- PET/CT (Positron Emission Tomography/Computed Tomography) Imaging for Safety and Tolerability and Diagnostic Performance of BAY1075553 in Patients With Prostate Cancer and Healthy VolunteersCompletedNCT01287845Phase 1
- A Study of MDV3100 to Evaluate Safety, Tolerability, Pharmacokinetics and Efficacy of in Prostate Cancer PatientsCompletedNCT01284920Phase 1/2
- Metabolic Changes in Prostate Cancer Patients With Androgen-ablation Therapy (AAT)CompletedNCT01284608
- A Study of the Safety and Pharmacokinetics of Escalating Doses of DSTP3086S in Patients With Metastatic Castration-Resistant Prostate CancerCompletedNCT01283373Phase 1
- A Pilot Study of 123I-MIP-1072 SPECT/CT Imaging With Optional Compact Gamma Camera Probe Imaging in Men With Prostate Cancer Undergoing ProstatectomyWithdrawnNCT01279785
- Trial of Vaccine Therapy With mRNA- Transfected Dendritic Cells in Patients With Androgen Resistant Metastatic Prostate CancerCompletedNCT01278914Phase 1/2
- Pilot Study of Secondary Causes of Osteopenia/Osteoporosis in Adults With Breast and Prostate CancerCompletedNCT01277562
- Effect of Guided Imagery and Progressive Muscle Relaxation as a Means to Improve the Psychological Well-being and the Quality of Life for Patients With Breast and Prostate CancerCompletedNCT01275872Not applicable
- Biomarkers in Bone Marrow and Blood Samples From Patients With Prostate Cancer Treated With KetoconazoleWithdrawnNCT01275651
- Blood for Immune Response to Provenge® in HRPCWithdrawnNCT01274572
- Radiation Therapy in Treating Patients With Relapsed Prostate Cancer After SurgeryCompletedNCT01272050Phase 3
- A First-in-Man, Phase I Evaluation of A Single Cycle of Prohibitin Targeting Peptide 1 in Patients With Metastatic Prostate Cancer and ObesityTerminatedNCT01262664Phase 1
- Study to Find Maintenance Dose for Periodic Administration of ASP3550CompletedNCT01261572Phase 2
- Real-Time MV/kV Image Guided Radiation TherapyWithdrawnNCT01260909
- Adjuvant Androgen Suppression Plus Radiation Therapy for High-Risk Localized Adenocarcinoma ProstateCompletedNCT01255891Phase 2
- Feasibility of a Chemotherapy With Docetaxel-Prednisone for Castration-resistant Metastatic Prostate Cancer Elderly PatientsCompletedNCT01254513Phase 2
- Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing RegimenCompletedNCT01254279Phase 3
- BR55 in Prostate Cancer: an Exploratory Clinical TrialCompletedNCT01253213Early Phase 1
- International,Multi-Center,Open Label,Randomized Study Assessing the Safety and Efficacy of a Monthly Dosing Regimen of Ozarelix Versus Goserelin Depot in Men With Prostate CancerCompletedNCT01252693Phase 2
- Decision Support Interventions (DESI) for Prostate Cancer Screening and Treatment - Study 2CompletedNCT01244568Not applicable
- Metformin Hydrochloride as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Prostate CancerCompletedNCT01243385Phase 2
- Doxorubicin-GnRH Agonist Conjugate AEZS-108 in Treating Patients With Metastatic Hormone-Resistant Prostate CancerCompletedNCT01240629Phase 1/2
- A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate CancerCompletedNCT01234311Phase 3
- Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Docetaxel and Prednisone (CRPC)CompletedNCT01234025Phase 1/2
- Biomarkers of Bone Resorption in Metastatic Prostate CancerCompletedNCT01233557
- Study to Monitor the Effects of Androgen Suppression Treatment on the HeartCompletedNCT01230905Phase 4
- Study of Hypo-fractionated Proton Radiation for Low Risk Prostate CancerActive, not recruitingNCT01230866Phase 3
- Hyperpolarized Pyruvate Injection in Subjects With Prostate CancerCompletedNCT01229618Phase 1
- A Study to Determine the Maximum Tolerated Dose of ASG-5ME in Subjects With Castration-Resistant Prostate CancerCompletedNCT01228760Phase 1
- Using Ultrasound Spectrum Analysis (USA) to Guide Dose Escalated Prostate BrachytherapyCompletedNCT01227642Phase 1/2
- Changes in Brown Adipose Tissue Activity In Men Receiving Androgen Deprivation Therapy for Prostate CancerTerminatedNCT01226888
- Focal MR-Guided Focused Ultrasound Treatment of Localized Low-Intermediate Risk Prostate Cancer: Feasibility StudyCompletedNCT01226576Not applicable
- Multi-Institutional Registry for Prostate Cancer RadiosurgeryStatus unknownNCT01226004
- Novel Peptide Vaccination for Patients With Advanced Prostate CancerStatus unknownNCT01225471Phase 1/2
- Prostate Cancer, Androgen Deprivation Withdrawal and Intermittent ChemotherapyStatus unknownNCT01224405Phase 3
- Safety and Efficacy of POMx Capsules in Men With Recurrent Prostate Cancer: An 18-Month StudyCompletedNCT01220817Phase 2
- Micro-RNA Expression Profiles in High Risk Prostate CancerTerminatedNCT01220427
- ZOLEDRONIC ASSOCIATED With Hight Hypofractionated Radiotherapy Dose in Bone Metastases Vertebral Prostate AdenocarcinomaCompletedNCT01219790Phase 1
- Study of Abiraterone Acetate in Patients With Advanced Prostate CancerApproved for marketingNCT01217697
- Study of Bafetinib (INNO-406) as Treatment for Patients With Hormone-Refractory Prostate CancerCompletedNCT01215799Phase 2
- A Study Into the Effectivity and Safety of Firmagon, Prescribed for Treatment of Patients With Advanced Prostate CancerCompletedNCT01215526
- Efficacy and Safety Study of Toremifene Citrate for the Reduction in the Risk of New Bone Fracture Occurrences in Men With Prostate CancerWithdrawnNCT01214291Phase 3
- Impact of Tamsulosin on Voiding Patterns Following Early Catheter Removal After Robot-assisted Laparoscopic Radical ProstatectomyStatus unknownNCT01209988Not applicable
- CESAR Study in Prostate Cancer With Temsirolimus Added to Standard Docetaxel Therapy (CEPTAS)CompletedNCT01206036Phase 1/2
- PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-7548 in Patients With Prostate Cancer and Healthy VolunteersCompletedNCT01205321Phase 1
- Study to Investigate Adherence of Patients to Clodronate (Bonefos) TreatmentCompletedNCT01198457
- Vaccine Therapy in Curative Resected Prostate Cancer PatientsActive, not recruitingNCT01197625Phase 1/2
- Neoadjuvant Study of In-situ REIC/Dkk-3 in Prostate CancerWithdrawnNCT01197209Phase 1
- TroVax® In Subjects With Hormone Refractory Prostate Cancer (HRPC)TerminatedNCT01194960Phase 2
- Dutasteride in Treating Patients With Prostate CancerStatus unknownNCT01193855Phase 2
- Laser Based Focal Ablation of Low Grade Prostate CancerCompletedNCT01192438Not applicable
- Prostate HistoScanning for the Non-invasive Detection and Staging of Prostate Cancer and Characterization of Prostate Tissues (PHS-02)CompletedNCT01191931
- A Study of PNT2258 in Patients With Advanced Solid TumorsCompletedNCT01191775Phase 1
- Comprehensive Analysis of Hypoxia in Prostate Cancer: Diagnostic Markers and Prognostic SignificanceStatus unknownNCT01191099
- Efficacy and Safety Study of LE-DT to Treat Metastatic Castrate Resistant Prostate CancerWithdrawnNCT01188408Phase 2
- Comparison of Docetaxel/Prednisone to Docetaxel/Prednisone in Combination With OGX-011 in Men With Prostate CancerCompletedNCT01188187Phase 3
- A Randomized Study of Testosterone Replacement in Patients With Low Risk Hormone Refractory Prostate CancerCompletedNCT01187485Phase 1
- Phase 1 Study of Abiraterone Acetate in Castration-resistant Prostate CancerCompletedNCT01186484Phase 1
- Study of Treatment Choice in Patients With Localized Prostate CancerStatus unknownNCT01177865Not applicable
- Prostate Cancer Antigen 3 (PCA-3) Gene ProjectCompletedNCT01177436Not applicable
- The Role of Social Comparisons in Coping and Quality of Life Following a Prostate Cancer DiagnosisCompletedNCT01176526
- High Risk Prostate Cancer Prevention StudyCompletedNCT01174953Not applicable
- Temsirolimus and Vorinostat in Treating Patients With Metastatic Prostate CancerTerminatedNCT01174199Phase 1
- Ability of a New Design of Iodine 125 Seed to Maintain Intended Position When Implanted in the ProstateCompletedNCT01174017Phase 3
- Quality of Life in Men Undergoing Robotic Assisted Laparoscopic Radical Prostatectomy Versus Radical Retropubic ProstatectomyStatus unknownNCT01173952
- Imaging of Residual Tumor During ProstatectomyWithdrawnNCT01173146
- Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid TumorsCompletedNCT01172028Phase 1
- Autologous Dendritic Cell Therapy for Hormone-Refractory Metastatic Prostate CancerCompletedNCT01171729Phase 1/2
- FLAME: Investigate the Benefit of a Focal Lesion Ablative Microboost in Prostate CancerCompletedNCT01168479Phase 3
- Spaced Education to Optimize Prostate Cancer ScreeningCompletedNCT01168323Not applicable
- Window Study of ZD4054 in Metastatic Prostate CancerStatus unknownNCT01168141Not applicable
- Feasibility and Safety Study Using Preoperative High-Dose Single-Fraction Image-Guided Radiotherapy for Men Undergoing Radical Prostatectomy at High-Risk for Extraprostatic CancerWithdrawnNCT01163448Phase 1
- Open Label Prostate Cancer StudyCompletedNCT01162395Phase 1
- Biomarkers of Response to Taxotere in HRPC. ICORG 08-08, V2CompletedNCT01160705
- Phase I Sodium Selenite in Combination With Docetaxel in Castration-resistant Prostate CancerTerminatedNCT01155791Phase 1
- Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid TumorsCompletedNCT01155258Phase 1
- Human Telomerase Reverse Transcriptase Messenger RNA (hTERT mRNA) Transfected Dendritic Cell VaccinesWithdrawnNCT01153113Phase 1/2
- Surgery Combined With Intensity Modulated Radiation Therapy - Image-Guided Radiation Therapy (IMRT-IGRT) in Locally-advanced Prostate CancersCompletedNCT01148069Phase 2
- Safety and Efficacy Study of Dose-escalated Hypofractionated Radiotherapy For Prostate CancerCompletedNCT01146340Phase 1/2
- PET Acetate for Castrate-Resistant Prostate Cancer on ChemotherapyCompletedNCT01144897Phase 1
- Adoptive Transfer of Autologous T Cells Targeted to Prostate Specific Membrane Antigen (PSMA) for the Treatment of Castrate Metastatic Prostate Cancer (CMPC)Active, not recruitingNCT01140373Phase 1
- Prostate Cancer Localization With a Multiparametric Magnetic Resonance (MR) ApproachCompletedNCT01138527
- Comparing PET-CT Using C-11 Choline and 18F-Fluoromethylcholine in Patients With Metastatic Prostate CancerWithdrawnNCT01132599Phase 2
- Study in Men With Prostate Cancer to Assess the Safety, Pharmacokinetics and Testosterone-Lowering Efficacy of TAK-448TerminatedNCT01132404Phase 1/2
- Immediate Postoperative Adjuvant Hormonal Treatment in High Risk Localised or Locally Advanced Prostate Cancer Patients.CompletedNCT01123434
- Leuprorelin Associated With Radiotherapy Versus Leuprorelin Alone in T3 - T4 or pT3 (on Biopsy) N0, M0 Prostate CancerCompletedNCT01122121Phase 3